Covered recipient · General Payments record
RALPH A DELAROSA
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2021
$2,206.09
- Reported across 125 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $277.66 | 16 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $107.92 | 6 |
| Amgen Inc. | $53.90 | 3 |
| Amarin Pharma Inc. | $39.99 | 2 |
| Horizon Pharma plc | $20.04 | 1 |
| Lilly USA, LLC | $19.39 | 1 |
| Novo Nordisk AS | $15.39 | 1 |
| Acerta Pharma LLC | $12.22 | 1 |
| Althera Pharmaceuticals LLC | $8.81 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2021 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $17.33 | 04/27/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794344807 | CMS |
| AbbVie Inc. | $14.09 | 05/28/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794344809 | CMS |
| AbbVie Inc. | $11.39 | 06/02/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794344811 | CMS |
| AbbVie Inc. | $12.84 | 07/07/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794344813 | CMS |
| AbbVie Inc. | $22.44 | 09/01/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794344815 | CMS |
| AbbVie Inc. | $29.83 | 10/12/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794344817 | CMS |
| Althera Pharmaceuticals LLC | $8.81 | 10/13/2021 | Food and Beverage | Undisputed | 01/23/2026 | 800372258 | CMS |
| Amarin Pharma Inc. | $17.50 | 02/05/2021 | Food and Beverage | Undisputed | 01/23/2026 | 815426775 | CMS |
| Amarin Pharma Inc. | $22.49 | 06/23/2021 | Food and Beverage | Undisputed | 01/23/2026 | 815426779 | CMS |
| Amgen Inc. | $17.72 | 02/10/2021 | Food and Beverage | Undisputed | 01/23/2026 | 825704033 | CMS |
| Amgen Inc. | $19.17 | 03/17/2021 | Food and Beverage | Undisputed | 01/23/2026 | 826413509 | CMS |
| Amgen Inc. | $17.01 | 05/03/2021 | Food and Beverage | Undisputed | 01/23/2026 | 826413513 | CMS |
| AstraZeneca Pharmaceuticals LP | $12.22 | 03/12/2021 | Food and Beverage | Undisputed | 01/23/2026 | 829396389 | CMS |
| Horizon Therapeutics plc | $20.04 | 02/03/2021 | Food and Beverage | Undisputed | 01/23/2026 | 797109939 | CMS |
| Lilly USA, LLC | $19.39 | 05/11/2021 | Food and Beverage | Undisputed | 01/23/2026 | 818719077 | CMS |
| Novo Nordisk Inc | $15.39 | 04/14/2021 | Food and Beverage | Undisputed | 01/23/2026 | 811715619 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.